SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Unexpected Role: EGFR Protects Cancer Cells From Starving, University of Texas M. D. Anderson Cancer Center Study
May 7, 2008
 · 
1 min read
Lone Star Bio
Protein ‘Nixes’ Mitochrondria, Prompts Maturation Of Red Blood Cells, Baylor College of Medicine Study
May 5, 2008
 · 
1 min read
Lone Star Bio
MicroCT Of Skeleton Can ID Even The Subtlest Birth Defects, University of Texas Health Science Center Study
May 2, 2008
 · 
1 min read
Biotech Bay
Biotech Blossoms Anew
April 29, 2008
 · 
2 min read
Lone Star Bio
Mammography May Be Beneficial To All Women, Regardless Of Age
April 28, 2008
 · 
1 min read
Lone Star Bio
New Hybrid Hearing Device Combining Advantages Of Hearing Aids, Implants
April 28, 2008
 · 
1 min read
Lone Star Bio
Lip Balms and Glosses May Boost Skin Cancer Risks
April 28, 2008
 · 
1 min read
Lone Star Bio
Inaccuracies Revealed In Studies Of Cancer Treatment
April 23, 2008
 · 
1 min read
Drug Development
Chemotherapy Drug Cisplatin Fails To Improve Disease-free Survival; Results In More Colostomies, University of Texas M. D. Anderson Cancer Center Study
April 23, 2008
 · 
1 min read
Lone Star Bio
Stomach-Proof Gel Hints At Jab-Free Diabetes Treatment
April 22, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
February 19, 2026
 · 
7 min read
Press Releases
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
February 19, 2026
 · 
31 min read
Press Releases
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
February 19, 2026
 · 
5 min read
Press Releases
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
February 19, 2026
 · 
3 min read
Press Releases
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026
 · 
5 min read
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
 · 
3 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
 · 
10 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
 · 
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
 · 
1 min read
Load More